Suppr超能文献

当今经皮冠状动脉腔内血管成形术(PTCA)的治疗方法:操作过程、适用人群。血管成形术何时可替代药物治疗或搭桥手术?

Today's approach to PTCA: how it is performed, who might benefit. When can angioplasty replace medical therapy or bypass surgery?

作者信息

Moscucci M, Feldman T

机构信息

Beth Israel Hospital, Boston.

出版信息

J Crit Illn. 1993 Feb;8(2):185-8; 191-3; 197-208.

Abstract

The use of percutaneous transluminal coronary angioplasty has expanded tremendously over the past decade. Because equipment has improved and physicians' experience has increased, the procedure is often appropriate for patients with complex lesions or difficult coronary anatomies. Currently, stenoses are successfully opened in more than 90% of patients. Angioplasty is an alternative to medical therapy for patients with one- or two-vessel disease; in some patients with multivessel disease, it is an alternative to coronary artery bypass graft surgery. Among elderly patients, those who are poor candidates for bypass surgery, those who have had previous bypass surgery, and those with acute myocardial infarction or cardiogenic shock, coronary angioplasty may be particularly useful.

摘要

在过去十年中,经皮腔内冠状动脉成形术的应用得到了极大的扩展。由于设备有所改进且医生经验有所增加,该手术通常适用于患有复杂病变或冠状动脉解剖结构复杂的患者。目前,超过90%的患者狭窄病变得以成功开通。对于单支或双支血管病变的患者,血管成形术是药物治疗的一种替代方法;对于一些多支血管病变的患者,它是冠状动脉旁路移植手术的一种替代方法。在老年患者、那些不适合进行搭桥手术的患者、那些曾接受过搭桥手术的患者以及患有急性心肌梗死或心源性休克的患者中,冠状动脉成形术可能特别有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验